Showing results (191-200 of 258) with videos related to
Sort By:
Pageof 26
Anticancer Research|July 1, 2015
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group TrialHelena Linardou, Konstantine T Kalogeras, Ralf Kronenwett, et al.American Journal of Cancer Research|December 2, 2016
Disease evolution and heterogeneity in bilateral breast cancerElena Fountzilas, Vassiliki Kotoula, Flora Zagouri, et al.The Journal of Clinical Investigation|November 18, 2014
Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinomaJihun Kim, Cameron Fox, Shouyong Peng, et al.Histology and Histopathology|March 26, 2015
Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) studyHelen P Kourea, Vassiliki Kotoula, Angelos Koutras, et al.ESMO Open|June 25, 2019
Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumabG Mountzios, Vassiliki Kotoula, Georgia-Angeliki Kolliou, et al.Cancer Genomics & Proteomics|April 26, 2019
Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast CancerGeorgios Lazaridis, Vassiliki Kotoula, Eleni Vrettou, et al.Clinical Breast Cancer|December 15, 2018
Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient OutcomeVassiliki Kotoula, Kalliopi Tsakiri, Georgia-Angeliki Koliou, et al.Journal of Translational Medicine|May 18, 2016
MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancerHelen Gogas, Vassiliki Kotoula, Zoi Alexopoulou, et al.Cancer Genomics & Proteomics|February 29, 2020
Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Elderly Patients With Breast CancerAdamantia Nikolaidi, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.ESMO Open|November 2, 2019
Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG)George Zarkavelis, Vassiliki Kotoula, Georgia-Angeliki Kolliou, et al.Pageof 26